March 12, 2025

Firefighters May Face Higher Risk of Gliomas Associated With Gene Mutations Caused by Haloalkanes

Investigators examined the occurrence of gliomas caused by gene mutations related to exposure to certain chemical compounds among firefighters compared with in individuals with other occupations.

The ASCO Post

November 22, 2024

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

The Global Coalition for Adaptive Research announced an agreement to evaluate AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, in its GBM AGILE trial. The AZD1390 arm will be assessed ...

The ASCO Post

November 21, 2024

Neuro-Oncology Guidelines Reveal How AI Could Improve Brain Cancer Diagnosis, Monitoring, and Treatment

Researchers have developed new clinical practice recommendations on the use of artificial intelligence (AI) methods to more accurately diagnose, monitor, and treat patients with brain cancer.

The ASCO Post

January 25, 2023

Outcomes in Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Curative-Intent Treatment

In a study reported in the Journal of Clinical Oncology, Erker et al identified factors associated with better postrelapse survival among infants and young children with medulloblastoma relapsing afte...

The ASCO Post

May 25, 2021

Dual BRAF/MEK Inhibition Under Study in BRAF V600E–Mutant Gliomas

The combination of dabrafenib plus trametinib led to encouraging and durable responses in patients with low- and high-grade gliomas harboring BRAF V600E mutations, according to the results of the phas...

The ASCO Post

September 18, 2019

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

New multi-pronged strategy for treating advanced breast cancer earns Breakthrough Award

Roswell Park Comprehensive Cancer Center

July 01, 2025

New Study Shows Tiny Cuts Could Improve Brain Surgery: A Simpler, Safer Way to Treat Brain Tumors

A new study from doctors at Miami Neuroscience Institute, part of Baptist Health, highlights a gentler way to perform brain surgery, one that uses small tools and avoids the need for large openings in the skull.

Baptist Health South Florida

March 20, 2025

Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber/Boston Children's Team

An international team of clinical collaborators, led by physician scientists from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high-grade glioma.

Dana-Farber

October 07, 2024

Radiopharmaceutical Therapy May Offer Benefit in Patients With Refractory Meningioma

A radiopharmaceutical therapy has demonstrated early efficacy in patients with difficult-to-treat meningioma, according to findings presented at the 2024 American Society for Radiation Oncology (ASTRO...

The ASCO Post